SHC1 and neoplasm: The upregulation of key regulatory genes in the MAPK pathway, such as MAP2K1, MAP2K2 and SHC1, in tumour cells positive for the three integrin receptors further supports the involvement of the integrin‐MAPK signalling pathway in the functional maintenance of the C0 subpopulation.